Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Toxic Megacolon - A Three Case Presentation.

Dumitru IM, Dumitru E, Rugina S, Tuta LA.

J Crit Care Med (Targu Mures). 2017 Feb 18;3(1):39-44. doi: 10.1515/jccm-2017-0008. eCollection 2017 Feb.


HLA class II alleles in Romanian patients with chronic hepatitis C.

Gheorghe L, Rugină S, Dumitru IM, Franciuc I, Martinescu A, Balaş I.

Germs. 2015 Jun 2;5(2):44-9. doi: 10.11599/germs.2015.1070. eCollection 2015 Jun.


Increased rate of spontaneous clearance of hepatitis C virus in patients infected with HIV.

Dumitru IM, Rugina S, Alexandrescu L, Dumitru E.

J Gastrointestin Liver Dis. 2014 Dec;23(4):461-2. No abstract available.


Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients.

Gatell JM, Morales-Ramirez JO, Hagins DP, Thompson M, Keikawus A, Hoffmann C, Rugina S, Osiyemi O, Escoriu S, Dretler R, Harvey C, Xu X, Teppler H.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19532. doi: 10.7448/IAS.17.4.19532. eCollection 2014.


Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study.

Benea OE, Streinu-Cercel A, Dorobăţ C, Rugină S, Negruţiu L, Cupşa A, Duiculescu D, Chiriac C, Itu C, Prisăcariu LJ, Iosif I.

Germs. 2014 Sep 1;4(3):59-69. doi: 10.11599/germs.2014.1057. eCollection 2014 Sep.


Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania.

Anca IA, Furtunescu FL, Pleşca D, Streinu-Cercel A, Rugină S, Holl K.

Germs. 2014 Jun 2;4(2):30-40. doi: 10.11599/germs.2014.1053. eCollection 2014 Jun.


Concomitant CMV and Clostridium difficile colitis in an immunocompetent patient treated with Ganciclovir and fecal transplantation.

Dumitru IM, Dumitru E, Resul G, Curtali L, Paris S, Rugina S.

J Gastrointestin Liver Dis. 2014 Jun;23(2):221-2. No abstract available.


Simultaneous occurrence of two rare diseases: actinomycosis and melanoma of the rectum.

Dumitru E, Dumitru IM, Popescu R, Resul G, Bulbuc I, Rugina S.

J Gastrointestin Liver Dis. 2014 Mar;23(1):95-8.


A real life boceprevir use in treatment-experienced HCV genotype 1 patients with advanced fibrosis.

Gheorghe L, Iacob S, Simionov I, Caruntu F, Motoc A, Arama V, Preotescu L, Stefan I, Goldis A, Brisc C, Rugina S, Rednic N.

J Gastrointestin Liver Dis. 2014 Mar;23(1):45-50.


Disseminated tuberculosis in HIV-infected patients from the Regional HIV/AIDS Center Constanţa, Romania.

Rugină S, Dumitru IM, Resul G, Cernat RC, Petcu AE.

Germs. 2014 Mar 3;4(1):16-21. doi: 10.11599/germs.2014.1050. eCollection 2014 Mar.


Nine-year follow-up of HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.

Wanless RS, Rugină S, Ruţă SM, Dumitru IM, Cernat RC, Schwarzwald HL, Calles NR, Schutze GE, Schweitzer AM, Draper HR, Kline MW.

Germs. 2013 Sep 1;3(3):90-5. doi: 10.11599/germs.2013.1042. eCollection 2013 Sep 1.


Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.

Afdhal NH, Dusheiko GM, Giannini EG, Chen PJ, Han KH, Mohsin A, Rodriguez-Torres M, Rugina S, Bakulin I, Lawitz E, Shiffman ML, Tayyab GU, Poordad F, Kamel YM, Brainsky A, Geib J, Vasey SY, Patwardhan R, Campbell FM, Theodore D.

Gastroenterology. 2014 Feb;146(2):442-52.e1. doi: 10.1053/j.gastro.2013.10.012. Epub 2013 Oct 12.


Phylodynamic and phylogeographic patterns of the HIV type 1 subtype F1 parenteral epidemic in Romania.

Mbisa JL, Hué S, Buckton AJ, Myers RE, Duiculescu D, Ene L, Oprea C, Tardei G, Rugina S, Mardarescu M, Floch C, Notheis G, Zöhrer B, Cane PA, Pillay D.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):1161-6. doi: 10.1089/AID.2011.0390. Epub 2012 May 3.


Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents.

Blanche S, Bologna R, Cahn P, Rugina S, Flynn P, Fortuny C, Vis P, Sekar V, van Baelen B, Dierynck I, Spinosa-Guzman S.

AIDS. 2009 Sep 24;23(15):2005-13. doi: 10.1097/QAD.0b013e328330abaa.


Switching from a toxicity-causing antiretroviral to enfuvirtide in patients with HIV: the SWITCH TOX study.

Streinu-Cercel A, de Gorgolas M, Müller M, Portilla J, Rugina S, Böcher W, Staszewski S, Pulik P, Rowell L, Salgo M, Stoll M.

HIV Clin Trials. 2008 Nov-Dec;9(6):375-86. doi: 10.1310/hct0906-375.


HLA-B*5701 screening for hypersensitivity to abacavir.

Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A; PREDICT-1 Study Team.

N Engl J Med. 2008 Feb 7;358(6):568-79. doi: 10.1056/NEJMoa0706135.


Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.

Kline MW, Rugina S, Ilie M, Matusa RF, Schweitzer AM, Calles NR, Schwarzwald HL.

Pediatrics. 2007 May;119(5):e1116-20. Epub 2007 Apr 9.


Supplemental Content

Loading ...
Support Center